
News
New Roles for Avalere Senior Leadership
Avalere is pleased to announce the promotion of three leaders in its Evidence & Strategy and Market Access practices.
Avalere Announces Departure of President Elizabeth Carpenter, Appointment of Interim President Sarah Alwardt
Elizabeth Carpenter will step down as Avalere President. Sarah Alwardt will lead Avalere on an interim basis.
Avalere Health Welcomes Emily Lobelo as Vaccine Policy Lead
Emily Lobelo, who has served for 15 years at the CDC, brings extensive knowledge of the vaccine landscape to Avalere’s policy team.
Avalere Health Welcomes Lisa Joldersma as Strategic Advisor
As a strategic advisor to the Policy Practice, Lisa Joldersma adds deep expertise in Medicare, commercial and employer-based insurance, and state policy issues.
Laura Housman Joins Avalere, Strengthens Evidence & Strategy Team
As a new managing director in the Evidence & Strategy practice, Laura Housman brings deep expertise in the pharmaceutical, device, and healthcare industries.
Avalere Welcomes Return of Shareef Ghanem to Financial Services Team
Shareef Ghanem rejoins Avalere as a managing director, bringing more than 10 years of experience in due diligence, operations, and corporate strategy.
Avalere Health Announces Addition of Kelsey Lang to Policy Practice
The veteran health policy professional brings expertise in coverage, access, and reimbursement and experience working with providers, plans, and manufacturers.
Value-Based Pricing and Payment Expert Joins Avalere
Veteran health policy professional brings deep expertise in value assessment, pharmaceutical value-based pricing, and payment reform.
Avalere Expands Data and Analytics Focus with New Addition
Avalere Health welcomes Mandar Karhade, who supports healthcare outcomes research and data commercialization through innovation and advanced technology.
New Opportunity for Quality Reporting Led by Avalere Health and Academy of Nutrition and Dietetics Will Improve Treatment for People With Malnutrition
Global Malnutrition Composite Score Included in Inpatient Prospective Payment System Final Rule
Avalere Joins Fishawack Health
UK-based Fishawack Health, a leading global commercialization partner for the biopharmaceutical, medical technology, and wellness industries, released the following statement about the addition of Avalere Health to its group.
Avalere Enhances Market Access Capabilities with Additions
Avalere Health’s Market Access practice expands its team with recent hires bringing analytics, coverage strategy, and commercialization expertise.
Sean Creighton Strengthens Avalere’s Health Plan Team
Sean brings more than 2 decades of Medicare Advantage experience in industry and government.
Alex Du Joins Avalere Health’s Market Access Practice
Avalere Health welcomes Alex (Shuang) Du as an associate principal to its Market Access practice. He will support a variety of Avalere’s clients in navigating the evolving healthcare landscape.
Jessica Alessio Brings Revenue Cycle Expertise to Avalere Health
New hire brings years of access, reimbursement, and revenue-cycle experience, strengthening Avalere's Market Access practice.
Avalere Adds Sarah Alwardt as New Practice Director
Sarah Alwardt joins Avalere as the practice director of the Center for Healthcare Transformation.
New Hires Bolster Avalere Health’s Market Access Practice
Two new additions expand expertise in drug pricing, payer engagement, CMS coverage and payment, and strategic market access and commercialization.
Ryan Urgo Joins Avalere Health as Managing Director
Seasoned health policy professional brings significant expertise in federal legislation, drug pricing policy, delivery system reform, and federal and state programs that affect insurance coverage.
Luke Reardon Brings Pharmacy Supply Chain Expertise to Avalere Health
Luke Reardon has joined Avalere’s Financial Services Practice as principal, bringing with him 15 years of experience that ranges from financial consulting to pharmacy solutions strategies.
Jason Hall and Tom Hess Bring Additional Vaccine Expertise to Avalere
They bring more than 35 years of combined healthcare experience and expertise in the immunization development sector.